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Immunoglobulin A (IgA) is the most abundant immunoglobulin isotype produced in the body and it is estimated that around 80 % of all IgA-antibody-secreting cells (IgA-ASCs) reside in the gut mucosa. 1,2 The importance of secretory IgA is evidenced by the fact that mice deficient in the J-chain, which produce only monomeric IgA that cannot be secreted, show markedly decreased protection from intestinal toxins. 3 Similarly, mice that cannot secrete antibodies because they lack the polymeric Ig receptor (pIgR or secretory component) exhibit a higher susceptibility to primary Salmonella infections, 4 although they have normal recall responses. 5 However, other studies using mice deficient in IgA show that they can efficiently mount protective immune responses against respiratory and gastrointestinal mucosal pathogens. 6,7 Therefore, in spite of its massive production in mucosal tissues, the physiological significance of IgA is still being debated. Nonetheless, it has been proposed that, aside from its role in neutralizing toxins and protecting against pathogenic infections, IgA, owing to its lack of complement-activating capacity and its binding to the inhibitory Fc RI receptor, may play a role as a noninflammatory mechanism of " immune exclusion " in the gut. 8 -10 In this way, IgA may help to prevent local inflammation and systemic immune responses triggered by innocuous antigens and / or commensal flora. 2, 9, 11 In fact, although isolated IgA deficiency in humans translates into only a mild and often asymptomatic primary immunodeficiency, it has been associated with autoimmune pathologies such as celiac disease. 12 On the other hand, the migration of B cells and ASCs to the gut is critical for conferring protection against intestinal pathogens. 7,13 -16 B cells that lack gut-homing capacity confer poor protection against intestinal rotavirus infection, whereas guthoming B cells from IgA knockout mice are as protective as wild-type cells. 7 The latter example suggests that, at least for some infections, the capacity of ASCs to migrate to the gut may be more important than their capacity to secrete IgA in order to confer protective immune responses.
In this review, we will discuss our current understanding of the mechanisms imprinting tissue-specific migration onto activated B cells as well as their relationship and potential intersection with the complex mechanisms involved in the differentiation of IgA-ASCs in mucosal tissues.
HOMING OF NAIVE B CELLS
Naive B lymphocytes migrate to secondary lymphoid organs (lymph nodes, Peyer ' s patches (PPs), spleen), where they are activated by their cognate antigen. 17 Naive B cells use L-selectin (CD62L) to tether and roll on specialized postcapillary microvessels known as high endothelial venules (HEVs), which are found in peripheral lymph nodes (PLNs), mesenteric lymph nodes (MLNs), and PPs 18, 19 ( Figure 1 ). HEVs in PLNs and MLNs express L-selectin ligands, collectively known as peripheral node addressin. 20 -22 In addition, the chemokines CCL21 / SLC and CCL19 / ELC are presented in HEVs of LN and PPs and they bind to CCR7 expressed on naive B cells, 23 -26 Differentiation and homing of IgA-secreting cells
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Most antibody-secreting cells (ASCs) in mucosal tissues produce immunoglobulin A (IgA), the most abundant immunoglobulin in the body and the main class of antibody found in secretions. IgA-ASCs differentiate in the mucosal-associated lymphoid tissues and are usually considered as a homogeneous population of cells. However, IgA-ASCs that travel to the small intestine have unique characteristics in terms of their migratory requirements. These IgA-ASCs require the homing molecules 4 7 and CCR9 to interact with their ligands, mucosal addressin cell adhesion molecule-1 and CCL25, which are constitutively expressed in the small intestine. Indeed, recent work has shown that IgA-ASCs specific for the small bowel are generated under different conditions as compared with IgA-ASCs in other mucosal compartments. Moreover, the mechanisms inducing IgA class switching may also vary according to the tissue where IgA-ASCs differentiate. Here we describe the mechanisms involved in the differentiation of IgA-ASCs in mucosal compartments, in particular those involved in the generation of gut-homing IgA-ASCs.
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globulin class switching. 34 On the other hand, B cells can be activated by T cell-independent (TI) antigens, either type 1 (polyclonal activators, such as lipopolysaccharide (LPS), CpG, poli-IC) or type 2 (polysaccharides, such as capsular bacterial polysaccharides), and become short-lived IgM-ASCs, except in the peritoneal cavity and the gut mucosa, tissues that can also support TI IgA responses. 34 Some ASCs producing IgM or IgG (and, to a lesser extent, IgE or IgA) stay in the lymph node medulla or spleen red pulp as short-lived ASCs. 35 However, most ASCs leave lymphoid tissues and travel to the bone marrow, where a small fraction becomes long-lived plasma cells. 35, 36 CXCR4 and probably also 4 1, LFA-1, P-selectin ligands, and CD22 are important for ASC lodging retention and / or survival in the bone marrow. 37 
Figure 2
Activation of B cells in MALTs. DCs in peripheral mucosal tissues capture antigens and migrate to their respective draining lymph nodes (MALTs). Intestinal epithelial cells (IEC), as well as DCs in PPs and MLNs (GALT), express retinal dehydrogenase (RALDH) enzymes and therefore have the capacity to metabolize vitamin A from the diet into retinoic acid (RA). RA induces the expression of 4 7 and CCR9 in ASCs and probably also in B Mem , endowing them with the capacity to home to the small bowel. In addition, ASCs migrating to mucosal tissues express CCR10, and the CCR10 ligand MEC / CCL28 is expressed in all mucosal compartments. However, it is unknown where, when, and how CCR10 is upregulated on mucosal ASCs. In addition, B cells activated in the MALT microenvironment can switch to IgA-ASCs. IgA responses to TD antigens (e.g., proteins) require CD4 T-cell help and also TGF-1. The cytokines IL-5, IL-6, and IL-10 have also been reported as important for IgA secretion, although they are probably not directly involved in IgA class switching. IgA responses to TI antigens type 1 (e.g., LPS) or type 2 (e.g., bacterial capsule polysaccharides) do not require CD40-CD40L but rely on the cytokine APRIL, which are produced by activated DCs and macrophages. It is noteworthy that the enzyme iNOS, which synthesizes NO, is specifically expressed in MALT-DCs and is critical for both TD and TI IgA responses. In addition, RA also plays a role in promoting the generation of IgA-ASCs in GALT. APRIL, a proliferation-inducing ligand; ASC, antibody-secreting cells; B Mem, memory B cells; DC, dentritic cell; GALT, gut-associated lymphoid tissue; IEC, intestinal epithelial cell; LPS, lipopolysaccharide; MALT, mucosal-associated lymphoid tissue; NO, nitric oxide ; RA, retinoic acid; RALDH, retinal dehydrogenase; TD, thymus-dependent; TI, thymus-independent.
REVIEW
Some ASCs also home to sites of inflammation; this migration event is probably mediated by CXCR3. 35 Peyer ' s patches are the main secondary lymphoid organs where B cells differentiate into IgA-ASCs, 40 although IgAASCs can also differentiate in MLNs and the peritoneal cavity 2 ( Figure 2 ). That IgA-ASCs migrate preferentially to the gut was originally described more than 30 years ago. 41 -43 Although the presence of the specific antigen in the target tissue may play a role in the accumulation of IgA-ASCs in the gut (especially in late stages), their initial accumulation in the intestinal lamina propria is clearly antigen-independent, suggesting that it is regulated at the level of cell entry. 44, 45 Indeed, intestinal ASCs express 4 7 46 and this integrin (as well as its ligand MAdCAM-1) is critical for the homing of IgA-ASCs to the gut. 32 In addition, the chemokine receptor CCR10 is expressed on all ASCs located in mucosal compartments, 36,47 -49 and the CCR10 ligand CCL28 / MEC is expressed by most mucosal epithelial cells 48, 50 and selectively attracts IgA-ASCs. 49, 51 In fact, IgA-ASCs require CCL28 to home efficiently to the colon lamina propria. 52 To add even more complexity, a subset of IgA-ASCs also responds to the CCR9 ligand CCL25 / TECK, 53 and ASCs require CCR9 to home to the small intestine, at least in some experimental settings. 52, 54 It is noteworthy that although one report suggested that IgAASCs need both CCR9 and CCR10 for optimal migration to the small bowel, 52 another study showed that CCR9 and CCR10 play redundant roles in IgA-ASC homing to the small intestine during rotavirus infection. 55 The reasons for these discrepancies remain to be determined, although it is possible that inflammation upregulates CCL28 in the small bowel, thus making the homing of ASCs less dependent on CCR9.
Homing of IgA-ASCs to the intestinal lamina propria offers an efficient mechanism for locally delivering dimeric IgA that binds to the pIgR expressed on intestinal epithelial cells (IECs) to be finally secreted into the gut lumen. However, it should be considered that serum dimeric IgA can also bind directly to pIgR expressed on hepatocytes, transported to the bile ducts, and secreted via the bile into the gut lumen. 56 Such a mechanism may, in principle, decrease the relative importance of gut homing on intestinal IgA secretion. However, although hepatobiliary IgA transport is very efficient in mice and rats, it does not play a significant role in humans, which is probably due to species differences in the cellular localization and availability of pIgR, as well as the relative paucity of dimeric IgA in human serum, as compared to mice. 56, 57 Nevertheless, in spite of this potentially compensatory mechanism, memory B cells from 7 integrin-deficient mice exhibit a decreased capacity to confer protection against rotavirus infections, 7 implying that gut homing plays an important role in protective gut IgA responses.
T cell-dependent B-cell responses also generate long-lived B Mem . 34, 58 It is thought that B Mem recirculate through both lymphoid and peripheral tissues, but their migratory behavior has been difficult to study owing to their physiologically low abundance and lack of specific markers in mice. However, B Mem conferring protection against intestinal pathogens express 4 7, indicating that these cells, like their T-cell counterparts, respond to tissue-specific imprinting signals. 15, 16 It is noteworthy that IgA-ASCs have a short half-life in the intestinal mucosa, at least in the steady state, 59 and whether there are long-lived mucosal plasma cells is still an open question. 60 Thus, it is likely that IgA-ASCs need to be constantly replenished in the gut by recently activated naive B cells or B Mem .
MECHANISMS OF IMPRINTING OF GUT-HOMING B CELLS AND ASC
A great deal of evidence indicates that the tissue where the antigen is encountered influences the traffic pattern that lymphocytes acquire. For example, pathogens entering through the skin preferentially generate B and T lymphocytes with skinhoming receptors. 61 -65 Analogously, oral vaccination induces higher levels of the gut-homing integrin 4 7 on B and T cells than parenteral administration of the same antigen 13,14,66 -73 ( Figure 2 ). The functional relevance of this observation is suggested by the fact that among B Mem , only 4 7 + (but not 4 7 Neg ) cells confer protection against intestinal rotavirus, 7,15 indicating that gut tropism is required for immune defense against at least some tissue-restricted pathogens.
In the lymphoid microenvironment, dentritic cells (DCs) are essential for efficient T-cell activation. 74, 75 However, DCs can also influence B-cell responses by enhancing their differentiation to ASCs and their survival. 76, 77 It has also been shown that DCs can present unprocessed antigens to B cells in vivo 78 -80 and affect B-cell function in a tissue-specific fashion. For instance, PP-DCs promote class switching to IgA by activated B cells. 81 -83 Several reports have shown that DCs from PPs and MLNs (gut-associated lymphoid tissue (GALT)-DCs) are sufficient to induce 4 7 and CCR9 and gut-homing capacity on activated T cells. 84 -89 We have recently shown that, analogously, GALT-DCs but not DCs from other lymphoid organs imprint gut homing on activated B cells 90 ( Figure 2 ). Moreover, work from several groups has recently shown that subcapsular macrophages can also present lymph-borne antigens and activate naive B cells in PLNs. 91 -93 It will be interesting to determine whether a similar mechanism operates in MLNs and whether subcapsular macrophages can also imprint tissue-specific homing and / or promote specific IgA class switching in that tissue. In support of this possibility, macrophages can secrete B-cell activating factor (BAFF), 76 which can induce TI IgA class switching. Furthermore, intestinal lamina propria macrophages were reported to secrete retinoic acid (RA), 94 which is sufficient to imprint gut homing on activated B cells 90 
(see below).
What is the molecular mechanism controlling gut homing? Twenty-five years ago, it was shown that malnourished vitamin A-deficient rats exhibit impaired migration of recently activated mesenteric lymphocytes to the intestinal mucosa. 95 More recently, it was described that vitamin A-deficient rats show a marked decrease in the number of IgA-ASCs and CD4 T cells in the ileum. 96 However, the molecular basis for these observations was determined only recently in a seminal study by Iwata et al. that showed that mice depleted of vitamin A have a dramatic reduction in the number of effector / memory T cells in the gut mucosa but not elsewhere. 97 Concomitant in vitro experiments REVIEW showed that the vitamin A metabolite retinoic acid (RA) is sufficient to induce 4 7 and CCR9 on activated T cells, even in the absence of DCs. 97 In agreement with a major role for RA in gut-homing imprinting, blocking RA receptors of the RAR family significantly decreased the induction of 4 7 by GALTDCs. 97 Consistently, GALT-DCs, unlike DCs from other tissues, express retinal dehydrogenases (RALDH), which are essential enzymes for RA biosynthesis. 97 Although GALT-DCs are sufficient to induce gut-homing molecules on lymphocytes in vitro , it is formally possible that other sources of RA may contribute in vivo . For example, IECs express RALDH 97 and can synthesize RA in vitro . 98 Also, IECs, and perhaps other cells in the gut, may act as " RA donors " for DCs. In fact, it has been described recently that RA can be passively stored by DCs and used to imprint gut-homing lymphocytes. 99 Moreover, IP immunization efficiently generates gut-homing T cells, 86, 100, 101 and recently activated B cells (plasmablasts) may also be imprinted with gut tropism in the peritoneal cavity. 102 Thus, it is possible that gut-homing lymphocytes can be imprinted in regions other than GALT. Indeed, some nonintestinal viral infections also induce 4 7 + T cells 103 and there may be constitutive sources of RA in the lung mucosa 104 and liver. 105 Also, it remains to be determined whether RA synthesis can be induced in nonintestinal tissues under inflammatory or infectious conditions and whether there are additional RA-independent mechanisms of gut-homing imprinting. 106 It is also unknown how IgA-ASCs are imprinted to home to mucosal compartments other than the small bowel. CCR10 plays a role in IgA-ASC homing to colon, 52 mammary glands, 47 and probably other mucosal compartments, 49 but this chemokine receptor has not been reported to be upregulated in murine B cells in vivo or in vitro , so it is currently unknown where and how CCR10 is induced.
Peritoneal B1 B cells can also give rise to intestinal IgA-ASCs, although the extent of their contribution remains controversial, ranging from 1 to 50 % of all intestinal lamina propria IgA-ASCs, depending on the experimental system and readout. Earlier studies showed that almost half of the IgA-ASCs arise from peritoneal B1 B cells. 107, 108 Consistently, reconstitution experiments with bone marrow from T cell-deficient mice and peritoneal cavity B1 B cells, as well as mice deficient in B1 B cells, showed that virtually all intestinal lamina propria IgA-ASCs and secretory IgA against commensal flora were of B1 origin, suggesting that these cells account for most of the TI IgA responses, at least in the absence of T cells. 109 However, another study showed that, in gnotobiotic mice, conventional B2 B cells contribute most of the bacteria-specific intestinal IgA. 110 Moreover, in humans, peritoneal B1 B cells do not seem to be a significant source of lamina propria (LP) IgA-ASCs. 111 Thus, the relative contribution of B1 B cells to the pool of intestinal IgA-ASCs and their relevance to gut immunity remain to be determined.
It is also unknown which traffic molecules B1 cells need to home to the gut mucosa. 112 It is likely that B1-derived ASCs rely, at least in part, on the same homing imprinting mechanisms as B2-derived IgA-ASCs. A recent study showed that the peritoneal cavity environment can " instruct " B1 and B2 B cells to home back to the peritoneum via induction of CXCR5 expression, 102 which is critical for lodging of B1 B cells in body cavities. 113 Interestingly, the peritoneal environment also imprinted gut-homing capacity and IgA class switching / secretion on plasmablasts. 102 It remains to be determined whether this " peritoneal imprinting " relies on similar mechanisms such as GALT imprinting. In addition, TLR ligands also play an important role during peritoneal B1 B-cell mobilization by transiently downregulating integrin expression on B1 cells. 114 Can B cells change or modulate their homing potential? We and others have shown that gut-or skin-homing T cells can be " reprogrammed " in their migratory potential. Skin-homing T cells can be converted to gut-homing T cells and vice versa if they are stimulated with or without GALT-DCs or RA, respectively. 88, 89 Similarly, human B cells may also exhibit homing plasticity, 73 and we have shown that they can be re-educated and acquire or lose gut-homing potential when they are restimulated with or without RA, respectively 90 ( Figure 3 ). Given that terminally differentiated plasma cells do not divide, it is likely that homing plasticity occurs at the level of B Mem . Also, B Mem expressing either IgM or another immunoglobulin isotype different from IgA may switch to IgA when reactivated in mucosal-associated lymphoid tissues (MALTs). In fact, sequential immunoglobulin switching from IgG2b to IgA or, in humans, from IgA1 to IgA2, has been described. 115 On the other hand, IgA + B Mem remain IgA + regardless of where they are reactivated, although, given their homing plasticity, 90 they probably lose their gut-tropic capacity when reactivated in a nonintestinal context outside GALT.
DIFFERENTIATION OF IgA-ASC IN MUCOSAL TISSUES: MALTS VS. GALT
Peyer ' s patches were the first secondary lymphoid organs proposed as an inductive site for IgA-ASCs. 40 Hallmark molecular markers of immunoglobulin class switching, such as activationinduced cytidine deaminase (AID, essential for immunoglobulin class switching 116 ), and specific markers for IgA class switching, such as germline alpha transcripts and postswitch circular DNA transcripts, 117 are found at much higher levels in PPs as compared to MLNs and the peritoneal cavity. 118 In addition, IgA class switching is also higher in PPs as compared to the nasal-associated lymphoid tissues or bronchus-associated lymphoid tissues. 119 It is noteworthy that IgA class switching has also been reported in human and murine colon lamina propria 115, 120 as well as in murine small intestinal lamina propria. 121 However, other studies have failed to find molecular markers of IgA class switching in the small intestinal lamina propria of mice or humans, 118, 122, 123 arguing against a significant role of in situ IgA class switching in this compartment. In this regard, it should be considered that IgA class switching also takes place in the isolated lymphoid follicles (ILF) of the small intestine, which could contaminate lamina propria preparations. 123 However, ILF do not seem to efficiently generate IgA responses against orally administered antigens. 124, 125 Several different and sometimes seemingly contradictory pathways have been implicated for inducing IgA-ASCs REVIEW at mucosal tissues ( Table 1 ). The in vivo interplay and the relative roles of these mechanisms are probably determined by the context in which B cells are activated, e.g., the nature of the antigen, T cell help, site of activation, type of responder B cells (B1 or B2), and the contribution of Toll-like signals. In addition, as discussed below, the experimental conditions used may also have a significant impact in the final readout.
Role of TGF-1
IgA responses to TD antigens require transforming growth factor (TGF)-1, as well as CD4 T-cell " help, " the latter provided in the form of CD40L as well as cytokines such as IL-5 ( Figure 4A ). TGF-is critical for IgA responses in vivo , as TGF-1 knockout mice have impaired systemic and mucosal IgA responses. 126 Moreover, mice whose B cells are deficient in TGF-RII lack serum IgA 127 and do not mount systemic 127 or mucosal 128 antigen-specific IgA responses. Consistently, mice with B cells deficient in Smad2, which is critically involved in TGF-signaling, show decreased levels of serum IgA and have impaired antigenspecific IgA responses. 129 In addition, the cytokines IL-5 130 -133 and IL-6 134 -138 fulfill a complementary role in IgA production by promoting differentiation of ASCs and IgA secretion. Indeed, IgA levels are increased in mice overexpressing IL-6, 139 and IL-5 plays also an additional indirect role in IgA production by promoting B1 B-cell differentiation. 140 -143 Although TGF-plays a central role in the differentiation of IgA-ASCs, the relevant sources of TGF-in the gut are less clear. TGF-1 mRNA and / or protein have been detected in rodent jejunal enterocytes, 144 small and large bowel intestinal epithelium, 145 and intestinal lamina propria cells 145, 146 ( Figure 4A ). However, TGF-1 mRNA and protein are expressed at very low quantities in the steady-state noninflamed human intestine and become upregulated only during inflammation, e.g., in active inflammatory bowel disease. 146, 147 It is noteworthy that TGFmRNA transcripts have been detected in PP-DCs and CD103 + MLN-DCs. 148, 149 Moreover, CD103 + MLN-DCs and LP-DCs have been described to secrete active TGF-, as evidenced by their capacity to induce foxp3 + T REG , which is abrogated by blocking TGF-. 94, 149 However, parallel studies by others showed that TGF-1 needed to be added exogenously to obtain a significant induction of T REG in this system, 150, 151 suggesting that LPDCs and MLN-DCs are not a significant source of active TGF-1 in the gut. Thus, the actual contribution of gut-associated DCs to the pool of active TGF-1 needs further clarification. An additional possibility is that gut-associated DCs are in charge of activating latent TGF-1. In this regard, it has been shown that the 
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integrin v 8 is expressed on DCs and that it is critical to activate TGF-in vivo , 152 suggesting yet another potential mechanism by which gut-associated DCs (as well as DCs from other mucosal tissues) may promote IgA class switching. While the essential in vivo role of TGF-in IgA class switching is well demonstrated, its in vitro effects on IgA class switching / secretion seem to vary significantly depending on the experimental system. For instance, although TGF-1 consistently induces IgA production in LPS-activated splenocytes, 153 it suppresses the spontaneous IgA secretion by nonstimulated mononuclear cells from MLNs and PPs and almost completely blocks IL-5-induced IgA secretion in LPS-activated bulk splenocytes. 90, 153 Paradoxically, TGF-1 potentiates IL-5-induced IgA secretion in T cell-depleted MLN cells activated by LPS. 154, 155 Interestingly, the timing of IL-5 addition seems to be important in whether or not IL-5 synergizes with TGF-1 for IgA secretion. 156 Moreover, TGF-1 can only be present during the initial phase of in vitro human B-cell cultures, because it inhibits IgA secretion at later stages. 157 Nonetheless, it has been demonstrated that TGF-1 can truly promote IgA class switching at the clonal level, 158, 159 whereas IL-5 is mostly involved in postswitch differentiation / secretion. 155 Finally, while TGF-1 promotes molecular IgA class switching regardless of the activation stimuli, IgA secretion is induced only when B cells are activated with LPS but not by B-cell antigen receptor (BCR) crosslinking. 160 Thus, TGF-1 may have very different and even opposite effects on IgA production / secretion depending on seemingly minor differences in culture conditions, which may account, at least in part, for some discrepant reports on the role of TGF-1 and IL-5 in IgA class-switching / secretion. 90, 153 In summary, TGF-1 promotes germ-line IgA class switching and is essential for TD IgA responses in vivo . However, it may block ASC differentiation and IgA secretion in some in vitro settings. On the other hand, IL-5 and IL-6 are probably not directly involved in IgA class switching, but they contribute to ASC differentiation and immunoglobulin secretion (including IgA), thus complementing the role of TGF-1.
Role of nitric oxide
It was recently described that nitric oxide (NO) plays a critical role in IgA class switching and in the generation of IgAASCs 161 ( Figure 4 ). Mice deficient in the inducible isoform of nitric oxide synthase (iNOS) had a marked reduction in serum and intestinal IgA, but not in other immunoglobulin isotypes. A similar effect on IgA levels was observed when mice were treated with NO scavengers. It is noteworthy that iNOS was critical for both TD and TI IgA responses. TD IgA responses were affected because iNOS-deficient mice expressed decreased levels of TGF-RII and Smad proteins on B cells. 161 In addition, NO probably also affects DC function, as iNOS-deficient GALT-DCs had a significantly reduced capacity to produce APRIL (a proliferation-inducing ligand) and BAFF (B-cell activating factor / Blys), which may explain the lack of TI IgA responses (discussed below). Interestingly, iNOS expression is dependent on commensal flora and TLR signals, because DC from germ-free or MyD88 -/ -mice express very low levels of this enzyme. 161 In addition, given that serum IgA levels in iNOS knockout mice can be rescued by adoptively transferring wild-type LP-DCs, 161 iNOS expression by mucosal DCs 161 seems to be sufficient to allow IgA class switching / secretion. However, these results do APRIL, a proliferation-inducing ligand; ASC, antibody-secreting cell; BAFF, B-cell activating factor; GALT, gut-associated lymphoid tissue; iNOS, inducible nitric oxide synthase; NO, nitric oxide; RA, retinoic acid; TD, thymus-dependent; TI, thymus-independent; VIP, vasoactive intestinal peptide. a The effect can be direct or indirect in IgA class switching. b Includes lymphoid tissues associated with bronchus (BALT), mammary and salivary glands, and reproductive mucosa. REVIEW not exclude the possibility that NO secretion by other cells in the gut may also contribute to or be sufficient for sustaining IgA production. Also, although iNOS is necessary for IgA induction by GALT-DCs, 161 it has not been shown whether its expression is sufficient to confer IgA-inducing capacity to nonmucosal DCs.
APRIL and BAFF
As discussed above, in addition to TD IgA responses to proteins, B cells can respond to TI antigens. A fraction of TI IgA-ASCs derives from B1 B cells. In fact, in contrast to conventional B2 B cells, B1 B cells do not seem to require BCR stimulation to become IgAASCs. 162 However, the production of " natural " TI intestinal IgA against commensal flora requires the presence of PPs or MLNs, as shown in mice deficient in LN and GALT (alymphoplasia aly / aly mice) reconstituted with wild-type bone marrow, which lack intestinal IgA. 163 It is noteworthy that serum IgA is present in aly / aly mice, which lack intestinal IgA indicating that extraintestinal IgA switching can occur in the absence of GALT and PLN. 163 It has been determined that the cytokine APRIL is important for the induction of TI IgA-ASCs ( Figure 4B ). APRIL knockout mice show decreased mucosal TI IgA responses, and both APRIL and BAFF are sufficient to induce CD40-independent IgA class switching on murine naive B2 B cells, even without BCR stimulation, 164, 165 although in this case, either TGF-1, IL-4, or IL-10 need to be supplemented to the cultures. 167 APRIL and BAFF bind to the receptor TACI (transmembrane activator and CAML interactor), and TACI (but not BAFF-R) is essential for induction of IgA class switching by APRIL and BAFF in murine and human B cells. 164, 165, 169 However, although both APRIL and BAFF can induce IgA class switching in vitro , BAFF-deficient mice show only a mild decrease in IgA (despite a significant decrease in most other immunoglobulin isotypes), 166 which is consistent with a major role of APRIL -TACI but not BAFF -TACI interactions in IgA class-switching in vivo . It is noteworthy that IgA induction by TGF-1 plus LPS is largely TACI-and BAFF-R-independent. 165 In fact TACI-deficient mice have impaired TI but normal TD IgA immune responses 168 ( Table 1 ) . 
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BAFF and APRIL are expressed by cytokine-or TLR-activated DCs and monocytes, endowing them with the capacity to induce TI IgA class switching. 167 APRIL is also induced in IECs by commensal flora and TLR signals, especially in the distal part of the intestine 115 ( Figure 4B ). TLR signals also stimulate the production of the cytokine thymus stromal lymphopoietin (TSLP) by IECs, which in turn induces APRIL and IL-10 secretion by LPDCs, further contributing to their IgA-inducing capacity. 115 In human B cells, BAFF preferentially induces IgA1, while APRIL induces IgA2 (but not IgA1) class switching. 115, 167 In addition, APRIL induces IgA2 class switching starting from either IgM or sequentially from IgG1 or IgA1 class-switched cells. 115 The latter may represent a mechanism by which IgA1 induced in PP germinal centers becomes more resistant to intestinal proteases by switching locally to IgA2 in the colon lamina propria. 115 It is noteworthy that TACI is mutated in some common variable immunodeficiencies as well as in some isolated IgA immunodeficiencies, underscoring the relevance of IgAinducing mechanisms in human pathologies. 170 
Vasoactive intestinal peptide
Vasoactive intestinal peptide (VIP), which is highly expressed in postsynaptic parasympathetic nerve fibers and intrinsic neurons in the intestinal lamina propria, induces IgA1 and IgA2 secretion in anti-CD40-stimulated human B cells in a TGF--independent fashion 171 -173 ( Figure 4B ). In fact, TGF-1, as well as several other cytokines, did not induce IgA in this system, 173 illustrating yet another example of the variable effect of TGF-1 on IgA secretion in vitro . Interestingly, VIP may also indirectly contribute to IgA secretion by inducing nitric oxide synthase activity and NO production . 174, 175 It remains to be determined whether VIP plays a physiological role in IgA secretion and how it might influence other pathways that induce IgA secretion in the gut.
Role of GALT-DCs and RA
In addition to their imprinting effect on gut-homing T and B cells, 85, 86, 90 GALT-DCs can efficiently induce IgA-ASCs in vitro. 81 -83,90 Moreover, GALT-DCs can induce IgA secretion by BCR-stimulated B cells independent of T cells, 90 as has been shown in other settings. 109 This effect may be mediated, at least in part, by their capacity to produce active TGF-1 94, 148, 149, 152 and secrete APRIL. 115 However, GALT-DCs (and LP-DCs) can also induce and / or contribute to IgA class switching / secretion by secreting RA ( Figure 4B ). RA induces IgA secretion in LPS-activated splenocytes. 176 Interestingly, although RA also induces TGF-activity in LPS-activated splenocytes, 176 -178 the IgA-inducing effect of RA is only partially dependent on this cytokine. 176 Instead, RA-induced IgA secretion requires either T cells or exogenous IL-5, 180 and IL-5 is also essential for RA-induced IgA switching in LPS-activated splenocytes. 181 Moreover, GALT-DC require RA and IL-6 for optimal IgA induction in vitro . 83, 90 Interestingly, RA and IL-6 (and / or IL-5) can also synergize to induce IgA secretion in human B cells. 90 Thus, by inducing gut-homing potential and IgA secretion, RA links lymphocyte migration and function in the gut. 90, 112 Consistent with the effect of RA on IgA secretion in vitro , oral administration of an RA-receptor agonist significantly increases serum IgA levels in rats. 182 Moreover, treatment with either RA or an RA receptor agonist potentiates LPS-induced iNOS expression in several organs and also increases plasma levels of nitrate / nitrite in rats. 183, 184 Of note, the iNOS gene promoter has an RA response element that is directly activated by RA bound to its nuclear RAR / RXR heterodimeric receptor. 184, 185 As discussed above, iNOS expression is critical for the in vivo production of IgA. Thus, in addition to increasing IgA class switching, RA may indirectly contribute to IgA secretion by inducing iNOS expression.
Precursors of retinoids ( -carotene and retinyl esters) in the diet are absorbed from the gut lumen and can be converted to RA in IECs 98 and DCs near the germinal centers in PPs. 97 This proximity could explain the predominant IgA class switching observed in PPs as compared to MLNs. 118 Consistent with a role of vitamin A in gut IgA production, rats depleted of vitamin A have decreased levels of total IgA in intestinal lavages and decreased mucosal antigen-specific IgA responses. 186 -190 Also, vitamin A-depleted mice show impaired IgA secretion and protection at mucosal sites, 191, 192 as well as impaired IgA responses to oral toxins. 193 However, it should be kept in mind that vitamin A deficiency may have other effects on the immune system. In fact, the greater susceptibility to intestinal infections and toxins observed in these animals may also be explained, at least in part, by decreased pIgR expression and therefore decreased IgA secretion to the gut and other mucosal compartments. 186, 190, 192 Moreover, although vitamin A-deficient mice have a greatly reduced number of IgA-ASCs in the small bowel, 90, 96 they have normal serum IgA levels, 90 indicating that retinoids are not absolutely required for IgA production in other tissues.
In summary, given the critical role of RA in T-and B-cell guthoming imprinting, 90, 97 as well as its IgA-ASC-promoting potential in the gut, 90, 176 it is not surprising that vitamin A deficiency is associated with impaired intestinal immune responses 186 -194 and increased mortality. 195 Moreover, vitamin A supplementation correlates with a significant decrease in diarrhea and mortality in HIV-infected or malnourished children. 196 -199 
CONCLUSION
Although our understanding of the mechanisms inducing IgA-ASC homing to the small bowel has increased significantly, it is still unknown how IgA-ASCs are imprinted to migrate to other mucosal compartments, such as colon, lungs, and salivary and mammary glands. In this regard, the chemokine receptor CCR10 has been proposed as a " common " mucosal homing receptor for IgA-ASCs. However, where and how CCR10 is induced is still a mystery. It is also unclear to what extent B1 B cells contribute to the generation of gut IgA-ASCs and whether they obey the same gut-homing imprinting signals as conventional B2 B cells.
As we have discussed, IgA class switching and differentiation of IgA-ASCs is a complex process. TGF-1 and iNOS / NO play a critical role in the generation of IgA-ASCs in vivo . However, in the gut mucosa, other mechanisms may work independently of or in complement to TGF-1 to generate IgA-ASCs.
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APRIL -TACI interactions can induce TGF-1-independent and TI IgA class switching in the intestine. In addition, both VIP and RA also induce TGF-1-independent IgA class switching. Therefore, it will be important to determine the relative in vivo contributions and interrelationships among all these IgAinducing mechanisms. A systematic dissection of each pathway in different settings of B-cell activation (e.g., TD, TI, mucosal, systemic, with and without TLR signals) will be required to sort out these questions.
